Synthesis and antimicrobial activity of pyrimidine chalcones
Abstract In the realm of biochemical research, chalcones have been efficiently explored as antimicrobial agents. The present study focuses on the synthesis of pyrimidine chalcones, i.e. (E)-1-(6′-hydroxy-1′,3′-dimethyl-1′,2′,3′,4′-tetrahydro-2′,4′-dioxopyrimidin-5′-yl)-3-[-p-{(1″-aryl-1H-1″,2″,3″-triazol-4″-yl) methoxy}phenyl]-prop-2-ene-1-ones (7a–7i) by the reaction of 4-triazolomethoxybenzaldehyde, i.e. 4-{(1-aryl-1H-1,2,3-triazol-4-yl)methoxy}benzaldehyde (4a–4i) and 5-acetyl-1,3-dimethylbarbituric acid in (6) 50–80 % yields. The structures of these compounds were established on the basis of their FT-IR, 1H NMR, 13C NMR and mass spectral analysis. Compounds 7b–7i were screened for their in vitro antibacterial activity against Rhodococcus rhodochrous MTCC 265, a gram +ve bacteria and Escherichia coli, a gram −ve bacteria by the agar disc diffusion method. Graphical abstract.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2013 |
---|---|
Erschienen: |
2013 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
Medicinal chemistry research - 22(2013), 11 vom: 06. März, Seite 5624-5631 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kumar, Rakesh [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
---|
Anmerkungen: |
© Springer Science+Business Media New York 2013 |
---|
doi: |
10.1007/s00044-013-0555-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR000394270 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR000394270 | ||
003 | DE-627 | ||
005 | 20230519105831.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201001s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00044-013-0555-y |2 doi | |
035 | |a (DE-627)SPR000394270 | ||
035 | |a (SPR)s00044-013-0555-y-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kumar, Rakesh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Synthesis and antimicrobial activity of pyrimidine chalcones |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Springer Science+Business Media New York 2013 | ||
520 | |a Abstract In the realm of biochemical research, chalcones have been efficiently explored as antimicrobial agents. The present study focuses on the synthesis of pyrimidine chalcones, i.e. (E)-1-(6′-hydroxy-1′,3′-dimethyl-1′,2′,3′,4′-tetrahydro-2′,4′-dioxopyrimidin-5′-yl)-3-[-p-{(1″-aryl-1H-1″,2″,3″-triazol-4″-yl) methoxy}phenyl]-prop-2-ene-1-ones (7a–7i) by the reaction of 4-triazolomethoxybenzaldehyde, i.e. 4-{(1-aryl-1H-1,2,3-triazol-4-yl)methoxy}benzaldehyde (4a–4i) and 5-acetyl-1,3-dimethylbarbituric acid in (6) 50–80 % yields. The structures of these compounds were established on the basis of their FT-IR, 1H NMR, 13C NMR and mass spectral analysis. Compounds 7b–7i were screened for their in vitro antibacterial activity against Rhodococcus rhodochrous MTCC 265, a gram +ve bacteria and Escherichia coli, a gram −ve bacteria by the agar disc diffusion method. Graphical abstract | ||
650 | 4 | |a Barbituric acid |7 (dpeaa)DE-He213 | |
650 | 4 | |a Triazole |7 (dpeaa)DE-He213 | |
650 | 4 | |a Chalcone |7 (dpeaa)DE-He213 | |
650 | 4 | |a Antimicrobial activity |7 (dpeaa)DE-He213 | |
700 | 1 | |a Arora, Jyoti |4 aut | |
700 | 1 | |a Prasad, Ashok K. |4 aut | |
700 | 1 | |a Islam, Najmul |4 aut | |
700 | 1 | |a Verma, Anita K. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicinal chemistry research |d Cambridge, Mass. [u.a.] : Birkhäuser Boston, 1991 |g 22(2013), 11 vom: 06. März, Seite 5624-5631 |w (DE-627)SPR000381640 |w (DE-600)2191978-1 |x 1554-8120 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2013 |g number:11 |g day:06 |g month:03 |g pages:5624-5631 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00044-013-0555-y |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 22 |j 2013 |e 11 |b 06 |c 03 |h 5624-5631 |